Alice Borghi is Manager of the Digital Solutions team at the European Medicines Verification Organisation (EMVO) where she supports the team in overseeing the quality of the data uploaded in the European Medicines Verification Systems (EMVS) and in analysing the EMVS alerts. Prior to this role, in her 4-years’ experience within EMVO, she covered the role of Manager of the Quality Assurance team first and of Manager of the IT Projects afterwards. Alice holds a PhD in Biotechnology and Biochemistry and before joining EMVO, she worked in the Quality Assurance/Site Compliance department of different pharmaceutical companies.

The European Medicines Verification Organisation “The European Medicines Verification Organisation (EMVO) is the guarantee of patient security in Europe.” The European Medicines Verification Organisation (EMVO) has taken responsibility for advancing the formation of the European Medicines Verification System (EMVS). The EMVS is in accordance with the EU’s Falsified Medicines Directive (FMD) and the Delegated Regulation (DR). It ensures the implementation of a functioning, secure, interoperable and cost effective system across Europe. The infiltration of falsified medicines in the European supply chain is a major and continuous threat for the patient health and security. Because patient health and safety is of the utmost importance to the pharmaceutical industry, a comprehensive strategy at European Level is required. Therefore the European Medicines Verification Organisation (EMVO) was created as a joint initiative of EU stakeholders, representing manufacturers (Medicines for Europe, EFPIA, Affordable Medicines Europe), wholesalers (GIRP) and community pharmacists (PGEU).